bupivicaine hydrochloride

Generic: bupivicaine hydrochloride

Labeler: hf acquisition co llc, dba healthfirst
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name bupivicaine hydrochloride
Generic Name bupivicaine hydrochloride
Labeler hf acquisition co llc, dba healthfirst
Dosage Form INJECTION, SOLUTION
Routes
EPIDURAL INFILTRATION INTRACAUDAL PERINEURAL
Active Ingredients

bupivacaine hydrochloride 2.5 mg/mL

Manufacturer
HF Acquisition Co LLC, DBA HealthFirst

Identifiers & Regulatory

Product NDC 51662-1456
Product ID 51662-1456_b107e2b0-091e-b326-e053-2a95a90aa253
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA070583
Listing Expiration 2026-12-31
Marketing Start 2019-12-12

Pharmacologic Class

Classes
amide local anesthetic [epc] amides [cs] local anesthesia [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516621456
Hyphenated Format 51662-1456

Supplemental Identifiers

UNII
7TQO7W3VT8

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bupivicaine hydrochloride (source: ndc)
Generic Name bupivicaine hydrochloride (source: ndc)
Application Number ANDA070583 (source: ndc)
Routes
EPIDURAL INFILTRATION INTRACAUDAL PERINEURAL
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/mL
source: ndc
Packaging
  • 30 mL in 1 VIAL, SINGLE-DOSE (51662-1456-1)
source: ndc

Packages (1)

51662-1456-1 30 mL in 1 VIAL, SINGLE-DOSE (51662-1456-1)

Ingredients (1)

bupivacaine hydrochloride (2.5 mg/mL)

Linked Drug Pages (1)

BUPIVICAINE HYDROCHLORIDE ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["EPIDURAL", "INFILTRATION", "INTRACAUDAL", "PERINEURAL"], "spl_id": "b107e2b0-091e-b326-e053-2a95a90aa253", "openfda": {"unii": ["7TQO7W3VT8"], "spl_set_id": ["99857946-6084-1bbd-e053-2a95a90af58c"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "30 mL in 1 VIAL, SINGLE-DOSE (51662-1456-1)", "package_ndc": "51662-1456-1", "marketing_start_date": "20191212"}], "brand_name": "BUPIVICAINE HYDROCHLORIDE", "product_id": "51662-1456_b107e2b0-091e-b326-e053-2a95a90aa253", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Amide Local Anesthetic [EPC]", "Amides [CS]", "Local Anesthesia [PE]"], "product_ndc": "51662-1456", "generic_name": "BUPIVICAINE HYDROCHLORIDE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BUPIVICAINE HYDROCHLORIDE", "active_ingredients": [{"name": "BUPIVACAINE HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA070583", "marketing_category": "ANDA", "marketing_start_date": "20191212", "listing_expiration_date": "20261231"}